47
Owned outright. Prosecuted globally. Zero licensed sensor IP.
Granted and pending patents across core optical measurement, hardware architecture, and signal processing domains.
Every claim in the stack — optical method, hardware architecture, signal processing — is owned, not licensed. Acquisition counsel gets a clean estate with no third-party entanglement.
Active prosecution in US, EU, JP, KR, and CN jurisdictions — extending exclusivity beyond a single product cycle.
Three claim layers. One unencumbered stack.
Optical Measurement Method
Hardware Architecture
Signal Processing Algorithms
Core claims covering near-infrared spectroscopic glucose quantification in whole blood without skin penetration. No enzymatic reference required.
Wearable form-factor integration, optical emitter-detector array geometry, and skin-tone agnostic calibration hardware — owned at the component level.
Proprietary real-time physiological data interpretation, noise-rejection models, and ISF-lag elimination logic — protected at the software and firmware layer.